Clinical trial

Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?

NCT01298180

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE4

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2021-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prader-Willi Syndromeunresolved

Growth Hormone Deficiencyunresolved

Interventions

Growth hormone (Genotonorm® or Omnitrope®)DRUG

DEXA, blood tests, H.G.P.O, osseous age.PROCEDURE

biopsyPROCEDURE

Sponsors & collaborators

University Hospital, Toulouselead sponsor

Mapped research locations

ParisFrance1 ToulouseFrance1 MarseilleFrance1 MontpellierFrance1 LyonFrance1 StrasbourgFrance1 LilleFrance1 BordeauxFrance1 NantesFrance1 NiceFrance1 DijonFrance1 GrenobleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01298180 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.